Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

about

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

Item

http://www.wikidata.org/entity/Q52570452

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@en

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@nl

type

Item

label

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@en

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@nl

prefLabel

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@en

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@nl

P1476

Tandem bispecific broadly neutralizing antibody - a novel approach to HIV-1 treatment.

@en

P2093

Guido Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Evolutionary and immunological implications of contemporary HIV-1 variation.

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.

Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

Diversity considerations in HIV-1 vaccine selection.

P31

scholarly article

P356

10.1172/JCI121078

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29683434

http://www.w3.org/2001/XMLSchema#string

P932

5983339

http://www.w3.org/2001/XMLSchema#string